Search Bar & Filters
Found 4 Actively Recruiting clinical trials
Actively Recruiting
This research aims to find out if a treatment called cryoneurolysis can reduce pain after reverse total shoulder replacement surgery RTSA. Cryoneurolysis uses cold to temporarily block a nerve in the shoulder. The study compares those who receive this treatment before surgery to those who do not, to see if it lowers pain and reduces the need for opioid pain medications after RTSA. The trial is a randomized controlled pilot study involving two groups one receiving cryoneurolysis of the suprascapular nerve before RTSA and one not receiving this treatment. Cryoneurolysis is applied pre-operatively to study its effect on pain control and opioid use. The study will measure outcomes over a 90-day period following surgery. Participants will be monitored through various assessments including opioid usage measured by morphine milligram equivalents, pain scores using the Pain Assessment Documentation Tool, shoulder range of motion evaluations, and patient-reported outcomes via the American Shoulder and Elbow Surgeons shoulder score. The study involves pre-operative treatment, surgery, and follow-up assessments over three months to evaluate safety and effectiveness.
Actively Recruiting
Researchers are evaluating the safety and effectiveness of MaioRegen Prime compared to standard debridement surgery in patients with deep osteochondral lesions of the knee. This study involves patients with lesions of varying cause, size, shape, and location, and aims to assess outcomes through clinical, subjective, and objective measures. Participants are randomly assigned in a 21 ratio to receive either the MaioRegen Prime osteochondral scaffold implant or standard debridement surgery. All patients will have follow-up visits at 15 days, 6 weeks, 3, 6, 12, 18, and 24 months after surgery, with annual visits continuing until the last patient reaches 24 months. The study collects various clinical scores and MRI assessments to evaluate cartilage repair and knee function. During the study, participants will undergo evaluations including knee function questionnaires, pain scales, quality of life assessments, and MRI scans. Researchers will monitor clinical outcomes such as knee function scores, pain levels, cartilage repair quality, and any safety events or re-interventions. The total participation lasts at least 24 months, with continued annual follow-ups to track long-term outcomes.
Actively Recruiting
Researchers are studying Medicare beneficiaries with Lumbar Spinal Stenosis LSS and Neurogenic Claudication NC to compare outcomes after two different procedures MILD Percutaneous Image-Guided Lumbar Decompression and Interspinous Process Decompression IPD. This observational study tracks patients treated since January 1, 2017, evaluating the rates of surgical and minimally invasive interventions as well as any harms related to these procedures over 24 months. The study uses Medicare claims data and does not require prior patient consent or IRB oversight. The study includes two groups of patients those who received the MILD procedure, involving partial decompression under image guidance by removing tissue and bone at the affected spinal level, and those who underwent IPD, a device-based decompression technique. Both groups are observed through Medicare data for two years after their initial procedure to assess the need for further surgeries or interventions and to monitor for any complications. Participants are followed for 24 months after their index procedure using Medicare claims data. Researchers monitor the rates of harms associated with the initial treatment and the frequency of additional surgical or minimally invasive interventions. Since this is an observational study, data collection relies on existing Medicare records without direct patient involvement, and the study will continue enrolling patients until the sponsor stops it.
Actively Recruiting
This research aims to gather real-world data on the outcomes of Boston Scientific neurostimulation systems used for pain management in everyday clinical practice. It focuses on evaluating the long-term effectiveness, economic value, and technical performance of these commercially approved neurostimulation devices when used according to their instructions. Participants will undergo a trial period with a Boston Scientific neurostimulation system for pain. Those who experience positive results from the trial may then receive a permanent implant of the neurostimulation system. The therapy will be personalized based on the investigators judgment and routine site care, following the studys inclusion and exclusion criteria. During the study, participants will be monitored as they receive neurostimulation therapy in real-world settings. Researchers will collect information on treatment outcomes and device performance over time. The study spans from 2012 to 2035, allowing for long-term observation of participants using these neurostimulation systems for pain relief.